Published in Eur J Immunol on November 01, 1993
Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J Clin Invest (1998) 1.33
Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PLoS One (2011) 1.04
Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media. Clin Infect Dis (2009) 1.02
Association of the TNF-alpha-308 (G-->A) polymorphism with self-reported history of childhood asthma. Hum Genet (2000) 0.98
Is the association between TNF-alpha-308 A allele and DMT1 independent of HLA-DRB1, DQB1 alleles? Mediators Inflamm (2006) 0.84
Genetic traits in common diseases. BMJ (1995) 0.76
Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus. Mediators Inflamm (2003) 0.75
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A (1997) 6.99
HL-A antigens and diabetes mellitus. Lancet (1974) 4.42
Evaluation of the potential carcinogenicity and genetic toxicity to humans of the herbicide acetochlor. Hum Exp Toxicol (1996) 3.53
Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet (1988) 3.50
Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. Lancet (1990) 3.46
Addison's disease--clinical studies. A report fo 108 cases. Acta Endocrinol (Copenh) (1974) 3.24
Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet (1992) 3.12
A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest (1992) 2.99
The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol (1997) 2.87
Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (1986) 2.83
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet (1993) 2.57
Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med (2000) 2.50
The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods (1982) 2.49
An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med (1993) 2.30
Interleukin 1: the first interleukin. Immunol Today (1990) 2.27
A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis (2001) 2.27
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation (1999) 2.17
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol. Br Med J (1969) 2.11
Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09
Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology (1994) 2.05
The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage (2006) 2.01
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. Ann Rheum Dis (2008) 2.01
MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev (1975) 1.97
Anti-adrenal, cellular hypersensitivity in Addison's disease. Clin Exp Immunol (1969) 1.95
Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol (1993) 1.95
A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum (1995) 1.85
Mechanisms of fever induced by recombinant human interferon. J Clin Invest (1984) 1.81
Anti-pancreatic cellular hypersensitivity in diabetes mellitus. Diabetes (1971) 1.77
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest (1991) 1.75
Restriction fragment length polymorphism of the insulin gene in diabetes mellitus. Diabetes (1982) 1.75
Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol (1987) 1.74
Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia (1980) 1.71
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol (1988) 1.70
Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol (2000) 1.68
Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63
Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet (1992) 1.63
Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood. Diabet Med (1992) 1.60
A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics (1994) 1.57
Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study. Ann Rheum Dis (2012) 1.56
Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol (1999) 1.54
Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia (1982) 1.54
Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr (1992) 1.52
Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ (1995) 1.50
Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr (1994) 1.50
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum (1994) 1.48
Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet (1997) 1.48
Comparison of breathing comfort during weaning with two ventilatory modes. Am J Respir Crit Care Med (1994) 1.47
Patient stratification for preventive care in dentistry. J Dent Res (2013) 1.46
Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia (1981) 1.46
Evidence that brain prostaglandin synthesis is not essential in fever. J Physiol (1976) 1.45
HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia (1981) 1.43
The posteroanterior chest radiograph in depressed sternum. Clin Radiol (1989) 1.43
Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia (1986) 1.42
Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol (1988) 1.40
Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest (1985) 1.40
Immunotherapy in pre-type 1 diabetes mellitus. Diabetologia (1990) 1.39
The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology. Regul Toxicol Pharmacol (1994) 1.39
Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity? J Autoimmun (1988) 1.38
The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation. J Immunol Methods (1982) 1.38
Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy (1985) 1.37
Anti-adrenal cellular hypersensitivity in Addison's disease. II. Correlation with clinical and serological findings. Clin Exp Immunol (1969) 1.35
The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabet Med (1987) 1.34
Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr (1994) 1.34
Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol (1994) 1.33
Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A (1995) 1.32
Organ specific antibodies in Addison's disease. Acta Med Scand Suppl (1966) 1.32
Sequence homologies between hsp60 and autoantigens. Immunol Today (1993) 1.32
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet (1997) 1.31
Soluble interleukin 2 receptor in atopic eczema. BMJ (1989) 1.28
Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol (2001) 1.28
Fast glycosylation of haemoglobin. Lancet (1979) 1.28
Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes (1986) 1.27
Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol (1991) 1.25
IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun (2001) 1.25
The pyrogenic and mitogenic actions of interleukin-1 are related. Nature (1983) 1.25
Purification and characterization of a novel soluble receptor for interleukin 1. J Exp Med (1991) 1.21
Fluorescent anti-colon and organ-specific antibodies in ulcerative colitis. Scand J Gastroenterol (1973) 1.21
Thermoregulation in rabbits during fever. J Physiol (1976) 1.20
Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. Arthritis Rheum (1985) 1.20
HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia (2010) 1.20
Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia (1994) 1.20
Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes (1987) 1.20
Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun (2003) 1.19
Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol (1995) 1.19
An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis (2000) 1.18
Anti-adrenal cellular hypersensitivity in Addison's disease. 3. Species-specificity and subcellular localization of the antigen. Clin Exp Immunol (1969) 1.18
A soluble form of the interleukin-1 receptor produced by a human B cell line. FEBS Lett (1990) 1.17
Effect on forearm arteries and veins of attenuation of the cardiac response to leg exercise. Clin Sci (1968) 1.17
Genetics of diabetes in Nauru: effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism. Diabetologia (1983) 1.17
Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes (2001) 1.17
Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol (1990) 1.16
Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol (Copenh) (1986) 1.14
Letter: HL-A and idiopathic Addison's disease. Lancet (1974) 1.14
Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia (1987) 1.13